- epinephrine, and/or
histamine neurotransmitter systems in the brain.
Monoaminergics include catecholaminergics (which can be
further divided into adrenergics...
-
Monoaminergic activity enhancers (MAE), also
known as catecholaminergic/serotonergic
activity enhancers (CAE/SAE), are a
class of
drugs that
enhance the...
-
monoamine neurotoxin, or
monoaminergic neurotoxin, is a drug that
selectively damages or
destroys monoaminergic neurons.
Monoaminergic neurons are neurons...
- Lisuride, sold
under the
brand name
Dopergin among others, is a
monoaminergic medication of the
ergoline family which is used in the
treatment of Parkinson's...
- This is a list of
investigational sleep drugs, or
drugs for the
treatment of
sleep disorders that are
currently under development for
clinical use but...
- serotonin–norepinephrine–dopamine
releasing agent (SNDRA).
Tryptamine is a
monoaminergic activity enhancer (MAE) of serotonin, norepinephrine, and
dopamine in...
-
addiction liability for
drugs of many classes,
including those that act on
monoaminergic, opioid, and
cholinergic neurotransmission.
These data
correlate well...
- signalling.
Drugs that can
cause mydriasis include:
Stimulants (typically
monoaminergics) such as amphetamines, cocaine, MDMA, and mephedrone. Anticholinergics...
- the
brand names Contralac (veterinary) and
Liserdol (clinical), is a
monoaminergic medication of the
ergoline group which is used as a
prolactin inhibitor...
-
Sotnikova TD, Mory R, et al. (May 2011). "TAAR1
activation modulates monoaminergic neurotransmission,
preventing hyperdopaminergic and hypoglutamatergic...
